Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:604-606
doi: 10.1161/CIRCULATIONAHA.105.600684
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grayburn, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grayburn, P. A.
Related Collections
Right arrow Valvular heart disease
Right arrow Echocardiography
Right arrow CV surgery: valvular disease

(Circulation. 2006;113:604-606.)
© 2006 American Heart Association, Inc.


Editorial

Assessment of Low-Gradient Aortic Stenosis With Dobutamine

Paul A. Grayburn, MD

From the Department of Internal Medicine, Division of Cardiology, Baylor University Medical Center, Dallas, Tex.

Correspondence to Paul A. Grayburn, MD, Baylor University Medical Center, Baylor Heart and Vascular Institute, 621 N Hall St, Suite H030, Dallas, TX 75226. E-mail paulgr@baylorhealth.edu


Key Words: Editorials • echocardiography • stenosis • surgery • valves


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Low-gradient aortic stenosis (AS) has been a vexing problem for cardiologists since its original description in 1980 by Carabello et al.1 In that study, 3 of 4 patients with low-gradient AS died at surgery, and the other patient had persistent severe heart failure postoperatively. Subsequent studies showed that although operative mortality is high, most patients survive aortic valve replacement (AVR), and some have dramatic improvement in symptoms and left ventricular (LV) function.2,3 The challenge facing clinicians is how to accurately distinguish those patients who will benefit from AVR from those who will not. The American College of Cardiology/American Heart Association guidelines for valvular heart disease recommend hemodynamic evaluation of low-gradient AS with dobutamine echocardiography to distinguish patients with fixed anatomic AS from those with flow-dependent ("relative") AS in patients with LV dysfunction.4 In the latter case, aortic valve area (AVA) is spuriously low because there is not enough forward flow to fully open the leaflets.5–7 To understand how dobutamine infusion helps sort out the dilemma of low-gradient AS, it is useful to revisit the hemodynamic principles that govern the relationship between AVA, flow, and gradient.

Article p 711


*    The Gorlin Formula
 
In 1951, Gorlin and Gorlin proposed the "hydraulic orifice equation" for calculation of valve area in valvular stenosis.8 The Gorlin formula was based on the fundamental equation: equation


Formula 1

in which valve area (A) is equal to transvalvular flow (F), divided by transvalvular velocity (V). In AS, the Gorlin formula is used to calculate AVA as: equation


Formula 2

Because transvalvular flow occurs during systole . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
E. Picano, P. Pibarot, P. Lancellotti, J. L. Monin, and R. O. Bonow
The emerging role of exercise testing and stress echocardiography in valvular heart disease.
J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2251 - 2260.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
I G Burwash, M Lortie, P Pibarot, R A de Kemp, S Graf, G Mundigler, A Khorsand, C Blais, H Baumgartner, J G Dumesnil, et al.
Myocardial blood flow in patients with low-flow, low-gradient aortic stenosis: differences between true and pseudo-severe aortic stenosis. Results from the multicentre TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study
Heart, December 1, 2008; 94(12): 1627 - 1633.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Bergler-Klein, G. Mundigler, P. Pibarot, I. G. Burwash, J. G. Dumesnil, C. Blais, C. Fuchs, D. Mohty, R. S. Beanlands, Z. Hachicha, et al.
B-Type Natriuretic Peptide in Low-Flow, Low-Gradient Aortic Stenosis: Relationship to Hemodynamics and Clinical Outcome: Results From the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) Study
Circulation, June 5, 2007; 115(22): 2848 - 2855.
[Abstract] [Full Text] [PDF]